{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:22:15Z","timestamp":1788967335725,"version":"build-2803163510"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"30","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2020,12,3]]},"abstract":"<jats:sec><jats:title\/><jats:p>Traditional Chinese Medicine (TCM) is one of the ancient and most accepted alternative medicinal systems in the world for the treatment of health ailments. World Health Organization recognizes TCM as one of the primary healthcare practices followed across the globe. TCM utilizes a holistic approach for the diagnosis and treatment of cancers. The tumor microenvironment (TME) surrounds cancer cells and plays pivotal roles in tumor development, growth, progression, and therapy resistance. TME is a hypoxic and acidic environment that includes immune cells, pericytes, fibroblasts, endothelial cells, various cytokines, growth factors, and extracellular matrix components. Targeting TME using targeted drug delivery and nanoparticles is an attractive strategy for the treatment of solid tumors and recently has received significant research attention under precise medicine concept. TME plays a pivotal role in the overall survival and metastasis of a tumor by stimulating cell proliferation, preventing the tumor clearance by the immune cells, enhancing the oncogenic potential of the cancer cells, and promoting tumor invasion. Hepatocellular Carcinoma (HCC) is one of the major causes of cancer-associated deaths affecting millions of individuals worldwide each year. TCM herbs contain several bioactive phytoconstituents with a broad range of biological, physiological, and immunological effects on the system. Several TCM herbs and their monomers have shown inhibitory effects in HCC by controlling the TME. This study reviews the fundamentals and applications of targeting strategies for immunosuppressing TME to treat cancers. This study focuses on TME targeting strategies using TCM herbs and the molecular mechanisms of several TCM herbs and their monomers on controlling TME.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026620666201019111524","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:38:44Z","timestamp":1603168724000},"page":"2789-2800","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery"],"prefix":"10.2174","volume":"20","author":[{"given":"Le-Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Chun\u2019an First People\u2019s Hospital (Zhejiang Provincial People's Hospital Chun\u2019an Branch), Hangzhou 311700, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Gang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People\u2019s Hospital (People\u2019s Hospital of Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People\u2019s Hospital (People\u2019s Hospital of Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Hua","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Chun\u2019an First People\u2019s Hospital (Zhejiang Provincial People's Hospital Chun\u2019an Branch), Hangzhou 311700, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People\u2019s Hospital (People\u2019s Hospital of Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Hu","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People\u2019s Hospital (People\u2019s Hospital of Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Fitzmaurice C.","year":"2019","unstructured":"Fitzmaurice C.; Abate D.; Abbasi N.; Abbastabar H.; Abd-Allah F.; Abdel-Rahman O.; Abdelalim A.; Abdoli A.; Abdollahpour I.; Abdulle A.S.M.; Abebe N.D.; Abraha H.N.; Abu-Raddad L.J.; Abualhasan A.; Adedeji I.A.; Advani S.M.; Afarideh M.; Afshari M.; Aghaali M.; Agius D.; Agrawal S.; Ahmadi A.; Ahmadian E.; Ahmadpour E.; Ahmed M.B.; Akbari M.E.; Akinyemiju T.; Al-Aly Z.; AlAbdulKader, A.M.; Alahdab, F.; Alam, T.; Alamene, G.M.; Alemnew, B.T.T.; Alene, K.A.; Alinia, C.; Alipour, V.; Aljunid, S.M.; Bakeshei, F.A.; Almadi, M.A.H.; Almasi-Hashiani, A.; Alsharif, U.; Alsowaidi, S.; Alvis-Guzman, N.; Amini, E.; Amini, S.; Amoako, Y.A.; Anbari, Z.; Anber, N.H.; Andrei, C.L.; Anjomshoa, M.; Ansari, F.; Ansariadi, A.; Appiah, S.C.Y.; Arab-Zozani, M.; Arabloo, J.; Arefi, Z.; Aremu, O.; Areri, H.A.; Artaman, A.; Asayesh, H.; Asfaw, E.T.; Ashagre, A.F.; Assadi, R.; Ataeinia, B.; Atalay, H.T.; Ataro, Z.; Atique, S.; Ausloos, M.; Avila-Burgos, L.; Avokpaho, E.F.G.A.; Awasthi, A.; Awoke, N.; Ayala Quintanilla, B.P.; Ayanore, M.A.; Ayele, H.T.; Babaee, E.; Bacha, U.; Badawi, A.; Bagherzadeh, M.; Bagli, E.; Balakrishnan, S.; Balouchi, A.; B\u00e4rnighausen, T.W.; Battista, R.J.; Behzadifar, M.; Behzadifar, M.; Bekele, B.B.; Belay, Y.B.; Belayneh, Y.M.; Berfield, K.K.S.; Berhane, A.; Bernabe, E.; Beuran, M.; Bhakta, N.; Bhattacharyya, K.; Biadgo, B.; Bijani, A.; Bin Sayeed, M.S.; Birungi, C.; Bisignano, C.; Bitew, H.; Bj\u00f8rge, T.; Bleyer, A.; Bogale, K.A.; Bojia, H.A.; Borz\u00ec, A.M.; Bosetti, C.; Bou-Orm, I.R.; Brenner, H.; Brewer, J.D.; Briko, A.N.; Briko, N.I.; Bustamante-Teixeira, M.T.; Butt, Z.A.; Carreras, G.; Carrero, J.J.; Carvalho, F.; Castro, C.; Castro, F.; Catal\u00e1-L\u00f3pez, F.; Cerin, E.; Chaiah, Y.; Chanie, W.F.; Chattu, V.K.; Chaturvedi, P.; Chauhan, N.S.; Chehrazi, M.; Chiang, P.P.C.; Chichiabellu, T.Y.; Chido-Amajuoyi, O.G.; Chimed-Ochir, O.; Choi, J.J.; Christopher, D.J.; Chu, D.T.; Constantin, M.M.; Costa, V.M.; Crocetti, E.; Crowe, C.S.; Curado, M.P.; Dahlawi, S.M.A.; Damiani, G.; Darwish, A.H.; Daryani, A.; das Neves, J.; Demeke, F.M.; Demis, A.B.; Demissie, B.W.; Demoz, G.T.; Denova-Guti\u00e9rrez, E.; Derakhshani, A.; Deribe, K.S.; Desai, R.; Desalegn, B.B.; Desta, M.; Dey, S.; Dharmaratne, S.D.; Dhimal, M.; Diaz, D.; Dinberu, M.T.T.; Djalalinia, S.; Doku, D.T.; Drake, T.M.; Dubey, M.; Dubljanin, E.; Duken, E.E.; Ebrahimi, H.; Effiong, A.; Eftekhari, A.; El Sayed, I.; Zaki, M.E.S.; El-Jaafary, S.I.; El-Khatib, Z.; Elemineh, D.A.; Elkout, H.; Ellenbogen, R.G.; Elsharkawy, A.; Emamian, M.H.; Endalew, D.A.; Endries, A.Y.; Eshrati, B.; Fadhil, I.; Fallah Omrani, V.; Faramarzi, M.; Farhangi, M.A.; Farioli, A.; Farzadfar, F.; Fentahun, N.; Fernandes, E.; Feyissa, G.T.; Filip, I.; Fischer, F.; Fisher, J.L.; Force, L.M.; Foroutan, M.; Freitas, M.; Fukumoto, T.; Futran, N.D.; Gallus, S.; Gankpe, F.G.; Gayesa, R.T.; Gebrehiwot, T.T.; Gebremeskel, G.G.; Gedefaw, G.A.; Gelaw, B.K.; Geta, B.; Getachew, S.; Gezae, K.E.; Ghafourifard, M.; Ghajar, A.; Ghashghaee, A.; Gholamian, A.; Gill, P.S.; Ginindza, T.T.G.; Girmay, A.; Gizaw, M.; Gomez, R.S.; Gopalani, S.V.; Gorini, G.; Goulart, B.N.G.; Grada, A.; Ribeiro Guerra, M.; Guimaraes, A.L.S.; Gupta, P.C.; Gupta, R.; Hadkhale, K.; Haj-Mirzaian, A.; Haj-Mirzaian, A.; Hamadeh, R.R.; Hamidi, S.; Hanfore, L.K.; Haro, J.M.; Hasankhani, M.; Hasanzadeh, A.; Hassen, H.Y.; Hay, R.J.; Hay, S.I.; Henok, A.; Henry, N.J.; Herteliu, C.; Hidru, H.D.; Hoang, C.L.; Hole, M.K.; Hoogar, P.; Horita, N.; Hosgood, H.D.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Hussen, M.M.; Ileanu, B.; Ilic, M.D.; Innos, K.; Irvani, S.S.N.; Iseh, K.R.; Islam, S.M.S.; Islami, F.; Jafari Balalami, N.; Jafarinia, M.; Jahangiry, L.; Jahani, M.A.; Jahanmehr, N.; Jakovljevic, M.; James, S.L.; Javanbakht, M.; Jayaraman, S.; Jee, S.H.; Jenabi, E.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joo, T.; Jungari, S.B.; J\u00fcrisson, M.; Kabir, A.; Kamangar, F.; Karch, A.; Karimi, N.; Karimian, A.; Kasaeian, A.; Kasahun, G.G.; Kassa, B.; Kassa, T.D.; Kassaw, M.W.; Kaul, A.; Keiyoro, P.N.; Kelbore, A.G.; Kerbo, A.A.; Khader, Y.S.; Khalilarjmandi, M.; Khan, E.A.; Khan, G.; Khang, Y.H.; Khatab, K.; Khater, A.; Khayamzadeh, M.; Khazaee-Pool, M.; Khazaei, S.; Khoja, A.T.; Khosravi, M.H.; Khubchandani, J.; Kianipour, N.; Kim, D.; Kim, Y.J.; Kisa, A.; Kisa, S.; Kissimova-Skarbek, K.; Komaki, H.; Koyanagi, A.; Krohn, K.J.; Bicer, B.K.; Kugbey, N.; Kumar, V.; Kuupiel, D.; La Vecchia, C.; Lad, D.P.; Lake, E.A.; Lakew, A.M.; Lal, D.K.; Lami, F.H.; Lan, Q.; Lasrado, S.; Lauriola, P.; Lazarus, J.V.; Leigh, J.; Leshargie, C.T.; Liao, Y.; Limenih, M.A.; Listl, S.; Lopez, A.D.; Lopukhov, P.D.; Lunevicius, R.; Madadin, M.; Magdeldin, S.; El Razek, H.M.A.; Majeed, A.; Maleki, A.; Malekzadeh, R.; Manafi, A.; Manafi, N.; Manamo, W.A.; Mansourian, M.; Mansournia, M.A.; Mantovani, L.G.; Maroufizadeh, S.; Martini, S.M.S.; Mashamba-Thompson, T.P.; Massenburg, B.B.; Maswabi, M.T.; Mathur, M.R.; McAlinden, C.; McKee, M.; Meheretu, H.A.A.; Mehrotra, R.; Mehta, V.; Meier, T.; Melaku, Y.A.; Meles, G.G.; Meles, H.G.; Melese, A.; Melku, M.; Memiah, P.T.N.; Mendoza, W.; Menezes, R.G.; Merat, S.; Meretoja, T.J.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Mihretie, K.M.M.; Miller, T.R.; Mills, E.J.; Mir, S.M.; Mirzaei, H.; Mirzaei, H.R.; Mishra, R.; Moazen, B.; Mohammad, D.K.; Mohammad, K.A.; Mohammad, Y.; Darwesh, A.M.; Mohammadbeigi, A.; Mohammadi, H.; Mohammadi, M.; Mohammadian, M.; Mohammadian-Hafshejani, A.; Mohammadoo-Khorasani, M.; Mohammadpourhodki, R.; Mohammed, A.S.; Mohammed, J.A.; Mohammed, S.; Mohebi, F.; Mokdad, A.H.; Monasta, L.; Moodley, Y.; Moosazadeh, M.; Moossavi, M.; Moradi, G.; Moradi-Joo, M.; Moradi-Lakeh, M.; Moradpour, F.; Morawska, L.; Morgado-da-Costa, J.; Morisaki, N.; Morrison, S.D.; Mosapour, A.; Mousavi, S.M.; Muche, A.A.; Muhammed, O.S.S.; Musa, J.; Nabhan, A.F.; Naderi, M.; Nagarajan, A.J.; Nagel, G.; Nahvijou, A.; Naik, G.; Najafi, F.; Naldi, L.; Nam, H.S.; Nasiri, N.; Nazari, J.; Negoi, I.; Neupane, S.; Newcomb, P.A.; Nggada, H.A.; Ngunjiri, J.W.; Nguyen, C.T.; Nikniaz, L.; Ningrum, D.N.A.; Nirayo, Y.L.; Nixon, M.R.; Nnaji, C.A.; Nojomi, M.; Nosratnejad, S.; Shiadeh, M.N.; Obsa, M.S.; Ofori-Asenso, R.; Ogbo, F.A.; Oh, I.H.; Olagunju, A.T.; Olagunju, T.O.; Oluwasanu, M.M.; Omonisi, A.E.; Onwujekwe, O.E.; Oommen, A.M.; Oren, E.; Ortega-Altamirano, D.D.V.; Ota, E.; Otstavnov, S.S.; Owolabi, M.O.; P A, M.; Padubidri, J.R.; Pakhale, S.; Pakpour, A.H.; Pana, A.; Park, E.K.; Parsian, H.; Pashaei, T.; Patel, S.; Patil, S.T.; Pennini, A.; Pereira, D.M.; Piccinelli, C.; Pillay, J.D.; Pirestani, M.; Pishgar, F.; Postma, M.J.; Pourjafar, H.; Pourmalek, F.; Pourshams, A.; Prakash, S.; Prasad, N.; Qorbani, M.; Rabiee, M.; Rabiee, N.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi, M.; Rahman, M.A.; Rajati, F.; Rana, S.M.; Raoofi, S.; Rath, G.K.; Rawaf, D.L.; Rawaf, S.; Reiner, R.C.; Renzaho, A.M.N.; Rezaei, N.; Rezapour, A.; Ribeiro, A.I.; Ribeiro, D.; Ronfani, L.; Roro, E.M.; Roshandel, G.; Rostami, A.; Saad, R.S.; Sabbagh, P.; Sabour, S.; Saddik, B.; Safiri, S.; Sahebkar, A.; Salahshoor, M.R.; Salehi, F.; Salem, H.; Salem, M.R.; Salimzadeh, H.; Salomon, J.A.; Samy, A.M.; Sanabria, J.; Santric Milicevic, M.M.; Sartorius, B.; Sarveazad, A.; Sathian, B.; Satpathy, M.; Savic, M.; Sawhney, M.; Sayyah, M.; Schneider, I.J.C.; Sch\u00f6ttker, B.; Sekerija, M.; Sepanlou, S.G.; Sepehrimanesh, M.; Seyedmousavi, S.; Shaahmadi, F.; Shabaninejad, H.; Shahbaz, M.; Shaikh, M.A.; Shamshirian, A.; Shamsizadeh, M.; Sharafi, H.; Sharafi, Z.; Sharif, M.; Sharifi, A.; Sharifi, H.; Sharma, R.; Sheikh, A.; Shirkoohi, R.; Shukla, S.R.; Si, S.; Siabani, S.; Silva, D.A.S.; Silveira, D.G.A.; Singh, A.; Singh, J.A.; Sisay, S.; Sitas, F.; Sobngwi, E.; Soofi, M.; Soriano, J.B.; Stathopoulou, V.; Sufiyan, M.B.; Tabar\u00e9s-Seisdedos, R.; Tabuchi, T.; Takahashi, K.; Tamtaji, O.R.; Tarawneh, M.R.; Tassew, S.G.; Taymoori, P.; Tehrani-Banihashemi, A.; Temsah, M.H.; Temsah, O.; Tesfay, B.E.; Tesfay, F.H.; Teshale, M.Y.; Tessema, G.A.; Thapa, S.; Tlaye, K.G.; Topor-Madry, R.; Tovani-Palone, M.R.; Traini, E.; Tran, B.X.; Tran, K.B.; Tsadik, A.G.; Ullah, I.; Uthman, O.A.; Vacante, M.; Vaezi, M.; Varona P\u00e9rez, P.; Veisani, Y.; Vidale, S.; Violante, F.S.; Vlassov, V.; Vollset, S.E.; Vos, T.; Vosoughi, K.; Vu, G.T.; Vujcic, I.S.; Wabinga, H.; Wachamo, T.M.; Wagnew, F.S.; Waheed, Y.; Weldegebreal, F.; Weldesamuel, G.T.; Wijeratne, T.; Wondafrash, D.Z.; Wonde, T.E.; Wondmieneh, A.B.; Workie, H.M.; Yadav, R.; Yadegar, A.; Yadollahpour, A.; Yaseri, M.; Yazdi-Feyzabadi, V.; Yeshaneh, A.; Yimam, M.A.; Yimer, E.M.; Yisma, E.; Yonemoto, N.; Younis, M.Z.; Yousefi, B.; Yousefifard, M.; Yu, C.; Zabeh, E.; Zadnik, V.; Moghadam, T.Z.; Zaidi, Z.; Zamani, M.; Zandian, H.; Zangeneh, A.; Zaki, L.; Zendehdel, K.; Zenebe, Z.M.; Zewale, T.A.; Ziapour, A.; Zodpey, S.; Murray, C.J.L. Global burden of disease cancer collaboration. global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 2019,5(12),1749-1768","journal-title":"JAMA Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/2213988501812010009","volume":"12","author":"Singh A.K.","year":"2018","unstructured":"Singh A.K.; Kumar R.; Pandey A.K.; Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr Chem Genomics Transl Med 2018,12,9-26","journal-title":"Curr Chem Genomics Transl Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Ferlay J.","year":"2015","unstructured":"Ferlay J.; Soerjomataram I.; Dikshit R.; Eser S.; Mathers C.; Rebelo M.; Parkin D.M.; Forman D.; Bray F.; Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015,136(5),E359-E386","journal-title":"Int J Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.21037\/jgo.2017.03.14","volume":"8","author":"Zamor P.J.","year":"2017","unstructured":"Zamor P.J.; deLemos A.S.; Russo M.W.; Viral hepatitis and hepatocellular carcinoma: etiology and management. J Gastrointest Oncol 2017,8(2),229-242","journal-title":"J Gastrointest Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","volume":"388","author":"Stanaway J.D.","year":"2016","unstructured":"Stanaway J.D.; Flaxman A.D.; Naghavi M.; Fitzmaurice C.; Vos T.; Abubakar I.; Abu-Raddad L.J.; Assadi R.; Bhala N.; Cowie B.; Forouzanfour M.H.; Groeger J.; Hanafiah K.M.; Jacobsen K.H.; James S.L.; MacLachlan J.; Malekzadeh R.; Martin N.K.; Mokdad A.A.; Mokdad A.H.; Murray C.J.L.; Plass D.; Rana S.; Rein D.B.; Richardus J.H.; Sanabria J.; Saylan M.; Shahraz S.; So S.; Vlassov V.V.; Weiderpass E.; Wiersma S.T.; Younis M.; Yu C.; El Sayed Zaki M.; Cooke G.S.; The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet 2016,388(10049),1081-1088","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18020405","volume":"18","author":"Tahmasebi Birgani M.","year":"2017","unstructured":"Tahmasebi Birgani M.; Carloni V.; Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy. Int J Mol Sci 2017,18(2),18","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/cdd.2017.161","volume":"25","author":"Adams J.M.","year":"2018","unstructured":"Adams J.M.; Cory S.; The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ 2018,25(1),27-36","journal-title":"Cell Death Differ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.14694\/EDBK_175561","volume":"37","author":"Weyandt J.D.","year":"2017","unstructured":"Weyandt J.D.; Thompson C.B.; Giaccia A.J.; Rathmell W.K.; Metabolic alterations in cancer and their potential as therapeutic targets. Am Soc Clin Oncol Educ Book 2017,37,825-832","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-019-0739-0","volume":"12","author":"Wu Q.","year":"2019","unstructured":"Wu Q.; Zhou L.; Lv D.; Zhu X.; Tang H.; Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J Hematol Oncol 2019,12(1),53","journal-title":"J Hematol Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","volume":"21","author":"Yang J.D.","year":"2011","unstructured":"Yang J.D.; Nakamura I.; Roberts L.R.; The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011,21(1),35-43","journal-title":"Semin Cancer Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20040840","volume":"20","author":"Roma-Rodrigues C.","year":"2019","unstructured":"Roma-Rodrigues C.; Mendes R.; Baptista P.V.; Fernandes A.R.; Targeting tumor microenvironment for cancer therapy. Int J Mol Sci 2019,20(4),20","journal-title":"Int J Mol Sci"},{"key":"ref=12","first-page":"2087","volume":"34","author":"Seretis F.","year":"2014","unstructured":"Seretis F.; Seretis C.; Youssef H.; Chapman M.; Colorectal cancer: seed and soil hypothesis revisited. Anticancer Res 2014,34(5),2087-2094","journal-title":"Anticancer Res"},{"key":"ref=13","first-page":"2507","volume":"10","author":"Husori D.I.","year":"2018","unstructured":"Husori D.I.; Patilaya P.; Sumantri I.B.; Khaisar N.E.; Acute toxicity studies of acanthus illicifolius leaves ethanolic extract on male mice. Drug Invent Today 2018,10,2507-2513","journal-title":"Drug Invent Today"},{"key":"ref=14","first-page":"1091","volume":"10","author":"Philip J.M.","year":"2018","unstructured":"Philip J.M.; Rebecca L.J.; Abraham H.M.; Venkatakrishnan C.J.; Chandran C.R.; Anbuselvi. antibacterial activity of phytochemicals against oral bacteria. Drug Invent Today 2018,10,1091-1093","journal-title":"Drug Invent Today"},{"key":"ref=15","first-page":"443","volume":"10","author":"Mustarichie R.","year":"2018","unstructured":"Mustarichie R.; Udin L.Z.; In Vitro Anticancer activity of extract fractions resulted from fermented endophytic fungi on taxus sumatrana. Drug Invent Today 2018,10,443-449","journal-title":"Drug Invent Today"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.amjoto.2010.07.019","volume":"32","author":"Nikakhlagh S.","year":"2011","unstructured":"Nikakhlagh S.; Rahim F.; Aryani F.H.N.; Syahpoush A.; Brougerdnya M.G.; Saki N.; Herbal treatment of allergic rhinitis: the use of nigella sativa. Am J Otolaryngol 2011,32(5),402-407","journal-title":"Am J Otolaryngol"},{"key":"ref=17","first-page":"554","volume":"10","author":"Kishore M.","year":"2018","unstructured":"Kishore M.; Abdulqader A.T.; Shihab Ahmad H.; Hanumantharao Y.; Anticancer and antibacterial potential of green silver nanoparticles synthesized from maytenus senegalensis (l.) leaf extract and their characterization. Drug Invent Today 2018,10,554-561","journal-title":"Drug Invent Today"},{"key":"ref=18","first-page":"2441","volume":"10","author":"Paul R.","year":"2018","unstructured":"Paul R.; Geetha R.V.; Evaluation of anti-inflammatory action of illicium verum - an in vitro study. Drug Invent Today 2018,10,2441-2444","journal-title":"Drug Invent Today"},{"key":"ref=19","volume":"2016","author":"Xu J.","year":"2016","unstructured":"Xu J.; Song Z.; Guo Q.; Li J.; Synergistic effect and molecular mechanisms of traditional chinese medicine on regulating tumor microenvironment and cancer cells. Bio med Res Int 2016,2016","journal-title":"Bio med Res Int"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20194719","volume":"20","author":"Laplagne C.","year":"2019","unstructured":"Laplagne C.; Domagala M.; Le Naour A.; Quemerais C.; Hamel D.; Fourni\u00e9 J.J.; Couderc B.; Bousquet C.; Ferrand A.; Poupot M.; Latest advances in targeting the tumor microenvironment for tumor suppression. Int J Mol Sci 2019,20(19),20","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","volume":"17","author":"Maimela N.R.","year":"2018","unstructured":"Maimela N.R.; Liu S.; Zhang Y.; Fates of CD8+ T cells in Tumor Microenvironment. Comput Struct Biotechnol J 2018,17,1-13","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.5772\/65319","author":"Hong M.","year":"2016","unstructured":"Hong M.; Wang N.; Feng Y.; Liver cancer treatment by chinese medicines and their active compounds. Anti-cancer Drugs - Nature, Synthesis and Cell; InTech: London 2016","journal-title":"Anti-cancer Drugs - Nature, Synthesis and Cell; InTech: London"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"Balkwill F.R.","year":"2012","unstructured":"Balkwill F.R.; Capasso M.; Hagemann T.; The tumor microenvironment at a glance. J Cell Sci 2012,125(Pt 23),5591-5596","journal-title":"J Cell Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00018-017-2686-7","volume":"75","author":"Ostroumov D.","year":"2018","unstructured":"Ostroumov D.; Fekete-Drimusz N.; Saborowski M.; K\u00fchnel F.; Woller N.; CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol Life Sci 2018,75(4),689-713","journal-title":"Cell Mol Life Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Najafi M.; Mortezaee K.; CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol 2019,234(6),8509-8521","journal-title":"J Cell Physiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/molecules24010009","volume":"24","author":"van Dalen F.J.","year":"2018","unstructured":"van Dalen F.J.; van Stevendaal M.H.M.E.; Fennemann F.L.; Verdoes M.; Ilina O.; Molecular repolarisation of tumour-associated macrophages. Molecules 2018,24(1),24","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcell.2015.00033","volume":"3","author":"Bhome R.","year":"2015","unstructured":"Bhome R.; Bullock M.D.; Al Saihati H.A.; Goh R.W.; Primrose J.N.; Sayan A.E.; Mirnezami A.H.; A top-down view of the tumor microenvironment: structure, cells and signaling. Front Cell Dev Biol 2015,3,33","journal-title":"Front Cell Dev Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"Ries C.H.","year":"2014","unstructured":"Ries C.H.; Cannarile M.A.; Hoves S.; Benz J.; Wartha K.; Runza V.; Rey-Giraud F.; Pradel L.P.; Feuerhake F.; Klaman I.; Jones T.; Jucknischke U.; Scheiblich S.; Kaluza K.; Gorr I.H.; Walz A.; Abiraj K.; Cassier P.A.; Sica A.; Gomez-Roca C.; de Visser K.E.; Italiano A.; Le Tourneau C.; Delord J.P.; Levitsky H.; Blay J.Y.; R\u00fcttinger D.; Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 2014,25(6),846-859","journal-title":"Cancer Cell"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cancers11101532","volume":"11","author":"Malfitano A.M.","year":"2019","unstructured":"Malfitano A.M.; Somma S.D.; Prevete N.; Portella G.; Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer. Cancers (Basel) 2019,11(10),11","journal-title":"Cancers (Basel)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.2174\/1568026617666170224121008","volume":"17","author":"Zhou M.","year":"2017","unstructured":"Zhou M.; Wen K.; Bi Y.; Lu H.; Chen J.; Hu Y.; Chai Z.; The application of stimuli-responsive nanocarriers for targeted drug delivery. Curr Top Med Chem 2017,17(20),2319-2334","journal-title":"Curr Top Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.18632\/oncotarget.3520","volume":"6","author":"Bovy N.","year":"2015","unstructured":"Bovy N.; Blomme B.; Fr\u00e8res P.; Dederen S.; Nivelles O.; Lion M.; Carnet O.; Martial J.A.; No\u00ebl A.; Thiry M.; J\u00e9rusalem G.; Josse C.; Bours V.; Tabruyn S.P.; Struman I.; Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget 2015,6(12),10253-10266","journal-title":"Oncotarget"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fonc.2014.00004","volume":"4","author":"Barbouri D.","year":"2014","unstructured":"Barbouri D.; Afratis N.; Gialeli C.; Vynios D.H.; Theocharis A.D.; Karamanos N.K.; Syndecans as modulators and potential pharmacological targets in cancer progression. Front Oncol 2014,4,4","journal-title":"Front Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","volume":"48","author":"Steichen S.D.","year":"2013","unstructured":"Steichen S.D.; Caldorera-Moore M.; Peppas N.A.; A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 2013,48(3),416-427","journal-title":"Eur J Pharm Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"Giraldo N.A.","year":"2019","unstructured":"Giraldo N.A.; Sanchez-Salas R.; Peske J.D.; Vano Y.; Becht E.; Petitprez F.; Validire P.; Ingels A.; Cathelineau X.; Fridman W.H.; Saut\u00e8s-Fridman C.; The clinical role of the TME in solid cancer. Br J Cancer 2019,120(1),45-53","journal-title":"Br J Cancer"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"Ma L.","year":"2019","unstructured":"Ma L.; Hernandez M.O.; Zhao Y.; Mehta M.; Tran B.; Kelly M.; Rae Z.; Hernandez J.M.; Davis J.L.; Martin S.P.; Kleiner D.E.; Hewitt S.M.; Ylaya K.; Wood B.J.; Greten T.F.; Wang X.W.; Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 2019,36(4),418-430.e6","journal-title":"Cancer Cell"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3748\/wjg.v24.i31.3500","volume":"24","author":"Zhang Q.","year":"2018","unstructured":"Zhang Q.; Lou Y.; Bai X.L.; Liang T.B.; Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World J Gastroenterol 2018,24(31),3500-3512","journal-title":"World J Gastroenterol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"15620","DOI":"10.1038\/ncomms15620","volume":"8","author":"Lawless S.J.","year":"2017","unstructured":"Lawless S.J.; Kedia-Mehta N.; Walls J.F.; McGarrigle R.; Convery O.; Sinclair L.V.; Navarro M.N.; Murray J.; Finlay D.K.; Glucose represses dendritic cell-induced T cell responses. Nat Commun 2017,8,15620","journal-title":"Nat Commun"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.it.2003.10.002","volume":"24","author":"Yaqoob P.","year":"2003","unstructured":"Yaqoob P.; Fatty acids as gatekeepers of immune cell regulation. Trends Immunol 2003,24(12),639-645","journal-title":"Trends Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.3892\/ol.2018.7946","volume":"15","author":"Fang M.","year":"2018","unstructured":"Fang M.; Yuan J.; Chen M.; Sun Z.; Liu L.; Cheng G.; Ying H.; Yang S.; Chen M.; The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and \u03b1-SMA. Oncol Lett 2018,15(4),4805-4812","journal-title":"Oncol Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000481246","volume":"93","author":"Nishida N.","year":"2017","unstructured":"Nishida N.; Kudo M.; Oncogenic signal and tumor microenvironment in hepatocellular carcinoma. Oncology 2017,93(Suppl. 1),160-164","journal-title":"Oncology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/1759-7714.12270","volume":"6","author":"Liu J.","year":"2015","unstructured":"Liu J.; Wang S.; Zhang Y.; Fan H.T.; Lin H.S.; Traditional Chinese medicine and cancer: History, present situation, and development. Thorac Cancer 2015,6(5),561-569","journal-title":"Thorac Cancer"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2095-4964(17)60345-5","volume":"15","author":"Lin W.F.","year":"2017","unstructured":"Lin W.F.; Lu J.Y.; Cheng B.B.; Ling C.Q.; Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment. J Integr Med 2017,15(4),282-287","journal-title":"J Integr Med"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/302426","author":"Yin S.Y.","year":"2013","unstructured":"Yin S.Y.; Wei W.C.; Jian F.Y.; Yang N.S.; Therapeutic applications of herbal medicines for cancer patients. Evidence-based Complementary and Alternative Medicine (In press)2013","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2015.537","volume":"4","author":"Nie J.","year":"2016","unstructured":"Nie J.; Zhao C.; Deng L.I.; Chen J.; Yu B.; Wu X.; Pang P.; Chen X.; Efficacy of traditional Chinese medicine in treating cancer. Biomed Rep 2016,4(1),3-14","journal-title":"Biomed Rep"},{"key":"ref=45","volume":"2","author":"Nathanael L.","year":"2017","unstructured":"Nathanael L.; Guang-Biab. Zhou; Bhavana, Prasher; Mitali, Mukerji;Zhu, Chen; Samir, Brahamachari; Noble, Denis; Auffray Charles; Sagner, M. Traditional knowledge-based medicine: a review of history: progress in preventive medicine. Prog Prev Med 2017,2","journal-title":"Prog Prev Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.gendis.2019.10.016","volume":"7","author":"Liao X.","year":"2019","unstructured":"Liao X.; Bu Y.; Jia Q.; Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes Dis 2019,7(3),370-379","journal-title":"Genes Dis"},{"key":"ref=47","first-page":"75","volume":"05","author":"Guan Y.","year":"2014","unstructured":"Guan Y.; He Q.; Liver Cancer: Zheng Classification of Qi Stagnation and Blood Stasis. Pharmacol 2014,05,75-82","journal-title":"Pharmacol"},{"key":"ref=48","volume":"2012","author":"Chen Z.","year":"2012","unstructured":"Chen Z.; Chen L.Y.; Wang P.; Dai H.Y.; Gao S.; Wang K.; Tumor microenvironment varies under different tcm zheng models and correlates with treatment response to herbal medicine. Evidence-based Complement. Altern Med 2012,2012(6)","journal-title":"Altern Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.joim.2018.05.002","volume":"16","author":"Ling C.","year":"2018","unstructured":"Ling C.; quan; Fan, J.; Lin, H. sheng; Shen, F.; Xu, Z. ye; Lin, L. zhu; Qin, S. kui; Zhou, W. ping; Zhai, X. feng; Li, B.; Zhou, Q. hui. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional chinese and western medicine. J Integr Med 2018,16,236-248","journal-title":"J Integr Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.13005\/ojc\/31.Special-Issue1.33","volume":"31","author":"Yadollahpour A.","year":"2015","unstructured":"Yadollahpour A.; Magnetic nanoparticles in medicine: a review of synthesis methods and important characteristics. Orient J Chem 2015,31,271-277","journal-title":"Orient J Chem"},{"key":"ref=51","first-page":"11451","volume":"8","author":"Yadollahpour A.","year":"2016","unstructured":"Yadollahpour A.; Hosseini S.A.A.; Jalilifar M.; Rashidi S.; Rai B.M.M.; Magnetic nanoparticle-based drug and gene delivery: a review of recent advances and clinical applications. Int J Pharm Technol 2016,8,11451-11466","journal-title":"Int J Pharm Technol"},{"key":"ref=52","first-page":"433","volume":"10","author":"Sweetha G.","year":"2018","unstructured":"Sweetha G.; Abraham A.; Dhanraj M.; Jain A.R.; Fabrication and evaluation of polylactic acid membrane for drug delivery system. Drug Invent Today 2018,10,433-436","journal-title":"Drug Invent Today"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/2395-3977.159538","volume":"1","author":"Lin N.","year":"2015","unstructured":"Lin N.; Zhang Y.; Mao X.; Application and perspectives of traditional chinese medicine in the treatment of liver cancer. Cancer Transl Med 2015,1,101","journal-title":"Cancer Transl Med"},{"key":"ref=54","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3428253","volume":"2017","author":"Yang Z.","year":"2017","unstructured":"Yang Z.; Liao X.; Lu Y.; Xu Q.; Tang B.; Chen X.; Yu Y.; Add-on therapy with traditional chinese medicine improves outcomes and reduces adverse events in hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Evidence-based Complementary and Alternative Medicine 2017,2017","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"H1430","DOI":"10.1111\/1750-3841.12518","volume":"79","author":"Wu R.","year":"2014","unstructured":"Wu R.; Ru Q.; Chen L.; Ma B.; Li C.; Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. J Food Sci 2014,79(7),H1430-H1435","journal-title":"J Food Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molimm.2017.12.002","volume":"110","author":"Nicholson S.E.","year":"2019","unstructured":"Nicholson S.E.; Keating N.; Belz G.T.; Natural killer cells and anti-tumor immunity. Mol Immunol 2019,110,40-47","journal-title":"Mol Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2014.03.002","volume":"289","author":"Lee J.","year":"2014","unstructured":"Lee J.; Lee S.J.; Lim K.T.; ZPDC glycoprotein (24 kDa) induces apoptosis and enhances activity of NK cells in N-nitrosodiethylamine-injected Balb\/c. Cell Immunol 2014,289(1-2),1-6","journal-title":"Cell Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.coi.2013.05.016","volume":"25","author":"Wong C.","year":"2013","unstructured":"Wong C.; Goldstein D.R.; Impact of aging on antigen presentation cell function of dendritic cells. Curr Opin Immunol 2013,25(4),535-541","journal-title":"Curr Opin Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4137\/BMI.S585","volume":"3","author":"Takei M.","year":"2008","unstructured":"Takei M.; Tachikawa E.; Umeyama A.; Dendritic cells promoted by ginseng saponins drive a potent th1 polarization. Biomark Insights 2008,3,269-286","journal-title":"Biomark Insights"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/vaccines1040527","volume":"1","author":"Terhune J.","year":"2013","unstructured":"Terhune J.; Berk E.; Czerniecki B.J.; Dendritic cell-induced th1 and th17 cell differentiation for cancer therapy. Vaccines (Basel) 2013,1(4),527-549","journal-title":"Vaccines (Basel)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1002\/cam4.1700","volume":"7","author":"Ni L.","year":"2018","unstructured":"Ni L.; Lu J.; Interferon gamma in cancer immunotherapy. Cancer Med 2018,7(9),4509-4516","journal-title":"Cancer Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.trecan.2017.07.005","volume":"3","author":"Salimian Rizi B.","year":"2017","unstructured":"Salimian Rizi B.; Achreja A.; Nagrath D.; Nitric oxide: the forgotten child of tumor metabolism. Trends Cancer 2017,3(9),659-672","journal-title":"Trends Cancer"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112524","volume":"250","author":"Li Z.","year":"2020","unstructured":"Li Z.; Hao H.; Tian W.; Jiao Y.; Deng X.; Han S.; Han J.; Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE). J Ethnopharmacol 2020,250","journal-title":"J Ethnopharmacol"},{"key":"ref=64","volume":"2017","author":"Yu D.","year":"2017","unstructured":"Yu D.; An G.Y.; Clinical effects of xihuang pill combined with chemotherapy in patients with advanced colorectal cancer. Evidence-based Complement. Altern Med 2017,2017","journal-title":"Altern Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biopha.2018.03.063","volume":"102","author":"Su L.","year":"2018","unstructured":"Su L.; Jiang Y.; Xu Y.; Li X.; Gao W.; Xu C.; Zeng C.; Song J.; Weng W.; Liang W.; Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1\/SEK1\/JNK1\/AP-1 pathway. Biomed Pharmacother 2018,102,1111-1119","journal-title":"Biomed Pharmacother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12885-019-5471-1","volume":"19","author":"Fan Y.","year":"2019","unstructured":"Fan Y.; Li S.; Ding X.; Yue J.; Jiang J.; Zhao H.; Hao R.; Qiu W.; Liu K.; Li Y.; Wang S.; Zheng L.; Ye B.; Meng K.; Xu B.; First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers. BMC Cancer 2019,19(1),279","journal-title":"BMC Cancer"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12013-013-9724-3","volume":"68","author":"Li W.","year":"2014","unstructured":"Li W.; Wang M.; Wang L.; Ji S.; Zhang J.; Zhang C.; Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cell Biochem Biophys 2014,68(2),427-436","journal-title":"Cell Biochem Biophys"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3892\/ol.2019.9946","volume":"17","author":"Ma Y.","year":"2019","unstructured":"Ma Y.; Feng C.; Wang J.; Chen Z.; Wei P.; Fan A.; Wang X.; Yu X.; Ge D.; Xie H.; Liu L.; Zhang Q.; Li X.H.; Hydroxyl safflower yellow A regulates the tumor immune microenvironment to produce an anticancer effect in a mouse model of hepatocellular carcinoma. Oncol Lett 2019,17(3),3503-3510","journal-title":"Oncol Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"9549315","DOI":"10.1155\/2019\/9549315","volume":"2019","author":"Jiang Y.X.","year":"2019","unstructured":"Jiang Y.X.; Chen Y.; Yang Y.; Chen X.X.; Zhang D.D.Y.X.; Screening five qi-tonifying herbs on m2 phenotype macrophages. Evid Based Complement Alternat Med 2019,2019,9549315-9549315","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-16-3122","volume":"23","author":"Brown J.M.","year":"2017","unstructured":"Brown J.M.; Recht L.; Strober S.; The promise of targeting macrophages in cancer therapy. Clin Cancer Res 2017,23(13),3241-3250","journal-title":"Clin Cancer Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-015-0465-5","volume":"13","author":"Li A.","year":"2015","unstructured":"Li A.; Shuai X.; Jia Z.; Li H.; Liang X.; Su D.; Guo W.; Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. J Transl Med 2015,13,100","journal-title":"J Transl Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2045-3701-1-29","volume":"1","author":"Jing Y.","year":"2011","unstructured":"Jing Y.; Han Z.; Zhang S.; Liu Y.; Wei L.; Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci 2011,1,29","journal-title":"Cell Biosci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1231","volume":"3","author":"Condeelis J.","year":"2003","unstructured":"Condeelis J.; Segall J.E.; Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003,3(12),921-930","journal-title":"Nat Rev Cancer"},{"key":"ref=74","volume":"2018","author":"Liang S.","year":"2018","unstructured":"Liang S.; Zou Y.; Gao J.; Liu X.; Lin W.; Yin Z.; Du J.; Zhang Y.; Chen Q.; Li S.; Cheng B.; Ling C.; The chinese medicine, jiedu recipe, inhibits the epithelial mesenchymal transition of hepatocellular carcinoma via the regulation of smad2\/3 dependent and independent pathways. Evid Based Complement Alternat Med 2018,2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3815786","author":"Hu S.","year":"2019","unstructured":"Hu S.; Zhu Y.; Xia X.; Xu X.; Chen F.; Miao X.; Chen X.; Ginsenoside rg3 prolongs survival of the orthotopic hepatocellular carcinoma model by inducing apoptosis and inhibiting angiogenesis. Anal Cell Pathol (In press)2019","journal-title":"Anal Cell Pathol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fphar.2019.00937","volume":"10","author":"Lu Z.","year":"2019","unstructured":"Lu Z.; Chang L.; Zhou H.; Liu X.; Li Y.; Mi T.; Tong D.; Arctigenin attenuates tumor metastasis through inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma via suppressing gsk3\u03b2-dependent wnt\/\u03b2-catenin signaling pathway in vivo and in vitro. Front Pharmacol 2019,10,937","journal-title":"Front Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2019.00086","volume":"7","author":"Nallanthighal S.","year":"2019","unstructured":"Nallanthighal S.; Heiserman J.P.; Cheon D-J.; The role of the extracellular matrix in cancer stemness. Front Cell Dev Biol 2019,7,86","journal-title":"Front Cell Dev Biol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.canlet.2014.10.021","volume":"356","author":"Song J.","year":"2015","unstructured":"Song J.; Ge Z.; Yang X.; Luo Q.; Wang C.; You H.; Ge T.; Deng Y.; Lin H.; Cui Y.; Chu W.; Yao M.; Zhang Z.; Gu J.; Fan J.; Qin W.; Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Lett 2015,356(2 Pt B),713-720","journal-title":"Cancer Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.28421","volume":"134","author":"Wright J.H.","year":"2014","unstructured":"Wright J.H.; Johnson M.M.; Shimizu-Albergine M.; Bauer R.L.; Hayes B.J.; Surapisitchat J.; Hudkins K.L.; Riehle K.J.; Johnson S.C.; Yeh M.M.; Bammler T.K.; Beyer R.P.; Gilbertson D.G.; Alpers C.E.; Fausto N.; Campbell J.S.; Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer 2014,134(4),778-788","journal-title":"Int J Cancer"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1158\/0008-5472.CAN-16-1297","volume":"76","author":"Liotta L.A.","year":"2016","unstructured":"Liotta L.A.; Adhere, degrade, and move: the three-step model of invasion. Cancer Res 2016,76(11),3115-3117","journal-title":"Cancer Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1472-6882-13-65","volume":"13","author":"Deng W.","year":"2013","unstructured":"Deng W.; Sui H.; Wang Q.; He N.; Duan C.; Han L.; Li Q.; Lu M.; Lv S.; A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration\/invasion of colorectal cancer by down-regulating MMP-2\/9 via inhibiting the activation of ERK\/MAPK signaling pathways. BMC Complement Altern Med 2013,13,65","journal-title":"BMC Complement Altern Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3892\/mmr.2018.9023","volume":"18","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Zhang S.; Liu J.; Fang B.; Yao J.; Cheng B.; Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial mesenchymal transition. Mol Med Rep 2018,18(1),911-919","journal-title":"Mol Med Rep"},{"key":"ref=83","doi-asserted-by":"crossref","DOI":"10.1242\/bio.046854","volume":"9","author":"Pang D.","year":"2020","unstructured":"Pang D.; Yang C.; Li C.; Zou Y.; Feng B.; Li L.; Liu W.; Luo Q.; Chen Z.; Huang C.; Polyphyllin I.I.; Inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the akt\/nf-kb pathway. Biol Open 2020,9(2)","journal-title":"Biol Open"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","volume":"25","author":"Morse M.A.","year":"2019","unstructured":"Morse M.A.; Sun W.; Kim R.; He A.R.; Abada P.B.; Mynderse M.; Finn R.S.; The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res 2019,25(3),912-920","journal-title":"Clin Cancer Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"Muz B.","year":"2015","unstructured":"Muz B.; de la Puente P.; Azab F.; Azab A.K.; The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) 2015,3,83-92","journal-title":"Hypoxia (Auckl)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cancers11030316","volume":"11","author":"Katayama Y.","year":"2019","unstructured":"Katayama Y.; Uchino J.; Chihara Y.; Tamiya N.; Kaneko Y.; Yamada T.; Takayama K.; Tumor neovascularization and developments in therapeutics. Cancers (Basel) 2019,11(3),11","journal-title":"Cancers (Basel)"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines5020034","volume":"5","author":"Rajabi M.","year":"2017","unstructured":"Rajabi M.; Mousa S.A.; The role of angiogenesis in cancer treatment. Biomedicines 2017,5(2),5","journal-title":"Biomedicines"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2015.02.015","volume":"754","author":"Yang F.","year":"2015","unstructured":"Yang F.; Li J.; Zhu J.; Wang D.; Chen S.; Bai X.; Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK\/MAPK and NF-\u03baB signaling pathway in H22 tumor-bearing mice. Eur J Pharmacol 2015,754,105-114","journal-title":"Eur J Pharmacol"},{"key":"ref=89","first-page":"725","volume":"23","author":"Xie T.X.","year":"2010","unstructured":"Xie T.X.; Xia Z.; Zhang N.; Gong W.; Huang S.; Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep 2010,23(3),725-732","journal-title":"Oncol Rep"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.18240\/ijo.2019.11.05","volume":"12","author":"Zhou Y.","year":"2019","unstructured":"Zhou Y.; Liu Y.; Chen J.; Sun Y.Z.; Li L.H.; Chen L.; Inhibition of \u03b2-elemene on the expressions of HIF-l\u03b1, VEGF and iNOS in diabetic rats model. Int J Ophthalmol 2019,12(11),1693-1698","journal-title":"Int J Ophthalmol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"21010","DOI":"10.1038\/srep21010","volume":"6","author":"Li X.","year":"2016","unstructured":"Li X.; Lin Z.; Zhang B.; Guo L.; Liu S.; Li H.; Zhang J.; Ye Q.; \u03b2-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci Rep 2016,6,21010","journal-title":"Sci Rep"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20174136","volume":"20","author":"Chen S.H.","year":"2019","unstructured":"Chen S.H.; Chang J.Y.; New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment. Int J Mol Sci 2019,20(17),20","journal-title":"Int J Mol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.18632\/oncotarget.24282","volume":"9","author":"Porcu C.","year":"2018","unstructured":"Porcu C.; Antonucci L.; Barbaro B.; Illi B.; Nasi S.; Martini M.; Licata A.; Miele L.; Grieco A.; Balsano C.; Copper\/MYC\/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. Oncotarget 2018,9(10),9325-9343","journal-title":"Oncotarget"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/2225-4110.124326","volume":"4","author":"Yang C.S.","year":"2014","unstructured":"Yang C.S.; Chen G.; Wu Q.; Recent scientific studies of a traditional chinese medicine, tea, on prevention of chronic diseases. J Tradit Complement Med 2014,4(1),17-23","journal-title":"J Tradit Complement Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ptr.2390","volume":"22","author":"Lee S.I.","year":"2008","unstructured":"Lee S.I.; Kim H.J.; Boo Y.C.; Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells. Phytother Res 2008,22(5),669-674","journal-title":"Phytother Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"62","DOI":"10.20517\/2394-5079.2015.59","volume":"2","author":"Sharma S.","year":"2016","unstructured":"Sharma S.; Tanwar A.; Gupta D.K.; Curcumin: An adjuvant therapeutic remedy for liver cancer. Hepatoma Res 2016,2,62","journal-title":"Hepatoma Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.3892\/ol.2018.7988","volume":"15","author":"Pan Z.","year":"2018","unstructured":"Pan Z.; Zhuang J.; Ji C.; Cai Z.; Liao W.; Huang Z.; Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol Lett 2018,15(4),4821-4826","journal-title":"Oncol Lett"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12906-019-2477-9","volume":"19","author":"Hu B.","year":"2019","unstructured":"Hu B.; An H.M.; Yan X.; Zheng J.L.; Huang X.W.; Li M.; Traditional Chinese medicine formulation yanggan jiedu sanjie inhibits TGF-B1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med 2019,19,67","journal-title":"BMC Complement Altern Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","volume":"50","author":"M\u00e9ndez-Blanco C.","year":"2018","unstructured":"M\u00e9ndez-Blanco C.; Fondevila F.; Garc\u00eda-Palomo A.; Gonz\u00e1lez-Gallego J.; Mauriz J.L.; Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp Mol Med 2018,50(10),1-9","journal-title":"Exp Mol Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.3892\/ol.2017.6059","volume":"13","author":"Rong L.W.","year":"2017","unstructured":"Rong L.W.; Wang R.X.; Zheng X.L.; Feng X.Q.; Zhang L.; Zhang L.; Lin Y.; Li Z.P.; Wang X.; Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition. Oncol Lett 2017,13(6),5028-5034","journal-title":"Oncol Lett"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153174","volume":"68","author":"Hong M.","year":"2020","unstructured":"Hong M.; Almutairi M.M.; Li S.; Li J.; Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma. Phytomedicine 2020,68","journal-title":"Phytomedicine"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00204-002-0346-6","volume":"76","author":"Chen Y.C.","year":"2002","unstructured":"Chen Y.C.; Shen S.C.; Lee W.R.; Lin H.Y.; Ko C.H.; Shih C.M.; Yang L.L.; Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 2002,76(5-6),351-359","journal-title":"Arch Toxicol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1038\/srep31298","volume":"6","author":"Hu Z.","year":"2016","unstructured":"Hu Z.; Yang A.; Su G.; Zhao Y.; Wang Y.; Chai X.; Tu P.; Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV. Sci Rep 2016,6,31298","journal-title":"Sci Rep"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3892\/ol.2016.4686","volume":"12","author":"Bao H.","year":"2016","unstructured":"Bao H.; Liu P.; Jiang K.; Zhang X.; Xie L.; Wang Z.; Gong P.; Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett 2016,12(2),1058-1066","journal-title":"Oncol Lett"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/0253-7613.91872","volume":"44","author":"Li L.K.","year":"2012","unstructured":"Li L.K.; Kuang W.J.; Huang Y.F.; Xie H.H.; Chen G.; Zhou Q.C.; Wang B.R.; Wan L.H.; Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo. Indian J Pharmacol 2012,44(1),78-81","journal-title":"Indian J Pharmacol"},{"key":"ref=106","volume":"2015","author":"Sunwoo Y.Y.","year":"2015","unstructured":"Sunwoo Y.Y.; Lee J.H.; Jung H.Y.; Jung Y.J.; Park M.S.; Chung Y.A.; Maeng L.S.; Han Y.M.; Shin H.S.; Lee J.; Park S.I.; Oldenlandia diffusa promotes antiproliferative and apoptotic effects in a rat hepatocellular carcinoma with liver cirrhosis. Evidence-based Complement. Altern Med 2015,2015(3)","journal-title":"Altern Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-018-0464-y","volume":"25","author":"Sharma I.","year":"2018","unstructured":"Sharma I.; Singh A.; Siraj F.; Saxena S.; IL-8\/CXCR1\/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma. J Biomed Sci 2018,25(1),62","journal-title":"J Biomed Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3748\/wjg.v17.i31.3605","volume":"17","author":"Jiang J.W.","year":"2011","unstructured":"Jiang J.W.; Chen X.M.; Chen X.H.; Zheng S.S.; Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol 2011,17(31),3605-3613","journal-title":"World J Gastroenterol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jep.2013.07.030","volume":"149","author":"Hu Y.","year":"2013","unstructured":"Hu Y.; Wang S.; Wu X.; Zhang J.; Chen R.; Chen M.; Wang Y.; Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol 2013,149(3),601-612","journal-title":"J Ethnopharmacol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S2095-4964(14)60038-8","volume":"12","author":"Ling C.Q.","year":"2014","unstructured":"Ling C.Q.; Yue X.Q.; Ling C.; Three advantages of using traditional Chinese medicine to prevent and treat tumor. J Integr Med 2014,12(4),331-335","journal-title":"J Integr Med"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-94-017-7405-5_5","author":"Zeng Z.","year":"2015","unstructured":"Zeng Z.; Xu X.; Chen D.; Effects of Traditional Chinese Medicine on DCs Under Tumor Microenvironment 2015,55-63","journal-title":"Effects of Traditional Chinese Medicine on DCs Under Tumor Microenvironment"},{"key":"ref=112","first-page":"3555","volume":"11","author":"Liu F.","year":"2019","unstructured":"Liu F.; Lou G.; Zhang T.; Chen S.; Xu J.; Xu L.; Huang C.; Liu Y.; Chen Z.; Anti-metastasis traditional Chinese medicine monomer screening system based on perinucleolar compartment analysis in hepatocellular carcinoma cells. Am J Transl Res 2019,11(6),3555-3566","journal-title":"Am J Transl Res"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186953","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186953\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:02:29Z","timestamp":1696914149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186953\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":112,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2020,12,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026620666201019111524","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}